Jennifer Regan's most recent trade in Accelerate Diagnostics Inc was a trade of 7,894 Restricted Stock Units done . Disclosure was reported to the exchange on May 29, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | Jennifer Regan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 7,894 | 0 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Jennifer Regan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 7,894 | 7,894 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Jennifer Regan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 4,737 | 12,631 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Jennifer Regan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2024 | 4,737 | 18,947 | - | - | Restricted Stock Units | |
| Accelerate Diagnostics Inc | Jennifer Regan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2024 | 66,667 | 66,667 | - | - | Restricted Stock Units |